Stephan Moll is an Oncology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 307 publications with 9,631 citations (h-index 44); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr
Chapel Hill, NC 275990001
Telephone
919-966-4996Registry record last updated 8 Jul 2007.
Clinical trials
- Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)
Sponsor: University of North Carolina, Chapel Hill
- Once Weekly Subcutaneous Ports for the Administration of Anticoagulants
Sponsor: University of North Carolina, Chapel Hill
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ARGENX US, INC.Program year20231 payment
- Diagnostica Stago, IncProgram year20231 payment
- Diagnostica Stago, IncProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Factor Xa inhibitor96%Eliquis65%Xarelto25%Fondaparinux Sodium10%Part D<11 patientsLow Molecular Weight Heparin4%Enoxaparin Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2004–2011 per NIH RePORTER. The latest:
- Thrombosis and Hemostasis Centers Research and Prevention Network
Univ of North Carolina Chapel Hill
FY2011$175,000U01DD000292 - Thrombosis and Hemostasis Centers Research and Prevention Network
Univ of North Carolina Chapel Hill
FY2010$200,000U01DD000292 - Thrombosis and Hemostasis Centers Research and Prevention Network
Univ of North Carolina Chapel Hill
FY2009$280,000U01DD000292
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adenovirus-Associated Thrombocytopenia, Thrombosis, and VITT-like Antibodies
New England Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”